KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Current Taxes: 2009-2024

Historic Current Taxes for Ionis Pharmaceuticals (IONS) over the last 8 years, with Dec 2024 value amounting to $34,000.

  • Ionis Pharmaceuticals' Current Taxes rose 146.34% to $101,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $101,000, marking a year-over-year increase of 146.34%. This contributed to the annual value of $34,000 for FY2024, which is 98.42% down from last year.
  • According to the latest figures from FY2024, Ionis Pharmaceuticals' Current Taxes is $34,000, which was down 98.42% from $2.2 million recorded in FY2023.
  • In the past 5 years, Ionis Pharmaceuticals' Current Taxes registered a high of $6.2 million during FY2022, and its lowest value of $34,000 during FY2024.
  • For the 3-year period, Ionis Pharmaceuticals' Current Taxes averaged around $2.8 million, with its median value being $2.2 million (2023).
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Current Taxes spiked by 17,258.33% in 2022, and later plummeted by 98.42% in 2024.
  • Yearly analysis of 5 years shows Ionis Pharmaceuticals' Current Taxes stood at $1.3 million in 2020, then slumped by 97.28% to $36,000 in 2021, then spiked by 17,258.33% to $6.2 million in 2022, then tumbled by 65.58% to $2.2 million in 2023, then plummeted by 98.42% to $34,000 in 2024.